Cited by 103Tuberculosis Research and EpidemiologyMycobacterium research and diagnosisInfectious Diseases and Tuberculosis

Evaluation of the Xpert MTB/RIF Ultra assay for direct detection of Mycobacterium tuberculosis complex in smear-negative extrapulmonary samples

Open access
Perez-Risco, Daniel, Rodriguez-Temporal, David, Valledor-Sanchez, Ivan, Alcaide, Fernando·2018·Journal of Clinical Microbiology

Abstract

complex (MTUBC) in clinical samples is essential for successful treatment. New techniques such as real-time PCR have been developed in order to facilitate rapid diagnosis, but their sensitivity is low in extrapulmonary specimens, due to the low bacillary load in such samples. A next-generation assay has recently been developed to try to overcome this limitation. The aim of this study was to analyze the effectiveness of the Xpert MTB/RIF Ultra (GX-Ultra) for the detection of MTUBC DNA in 108 smear-negative extrapulmonary specimens that were MTUBC culture positive. In addition, 40 extrapulmonary culture-negative samples and 20 samples with nontuberculous mycobacteria were tested to evaluate the specificity of the assay. All samples were collected between May 1999 and May 2017. The GX-Ultra detected DNA of MTUBC in 82 extrapulmonary specimens that were MTUBC culture positive (75.9% sensitivity; 95% confidence interval [CI], 66.6 to 83.4%). The assay was negative for all clinical specimens that were MTUBC culture negative and the samples with nontuberculous mycobacteria (100% specificity). Furthermore, two (1.8%) samples presented mutations related to rifampin resistance. The highest sensitivity was obtained in samples of lymph nodes (94.1%) and nonsterile fluids (93.7%), followed by tissue specimens (86.6%), stool material (80%), abscess aspirates (64.7%), and sterile fluids (60.5%). Pleural fluids, one of the least optimal samples for detecting DNA of MTUBC, were GX-Ultra positive in 10/21 (47.6%) of cases. In summary, GX-Ultra showed excellent specificity and high sensitivity in paubacillary specimens, making it a useful tool for rapid diagnosis of extrapulmonary tuberculosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/jcm.00659-18

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In urine, Xpert Ultra specificity against culture was 100% (74 to 100).

    “In urine, Xpert Ultra sensitivity and specificity against culture were 100% (74 to 100) and 100% (74 to 100), (1 study; 24 participants, 12 (50%) with tuberculosis) (Perez‐Risco 2018); Figure 15.”

    From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Perez‐Risco 2018

    The Results report 100% Xpert Ultra specificity for the culture-negative and nontuberculous-mycobacteria specimens overall. Our copy does not give a urine-specific specificity estimate or the stated 74–100 confidence interval, so it supports the overall result but not the urine-specific figure. (LLM, conf=0.78)

    Experimental — accuracy not yet measured
  • Perez-Risco 2018 found Xpert Ultra negative for all 20 culture-positive NTM specimens covering 18 species.

    “Perez‐Risco 2018 assessed Xpert Ultra specificity using 20 culture‐positive NTM specimens (covering a total of 18 species) and found that Xpert Ultra was negative for all specimens.”
  • In urine, Xpert Ultra sensitivity against culture was 100% (74 to 100).

    “In urine, Xpert Ultra sensitivity and specificity against culture were 100% (74 to 100) and 100% (74 to 100), (1 study; 24 participants, 12 (50%) with tuberculosis) (Perez‐Risco 2018); Figure 15.”

    From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Perez‐Risco 2018

    The Results report sensitivity by specimen group and refer to Table 1, but the passages in our copy do not give a urine-specific result. Searches for urine, the reported 100% sensitivity, and the sample counts did not locate the claimed urine estimate or its 74–100 interval. (LLM, conf=0.72)

    Experimental — accuracy not yet measured
  • In bone or joint aspirate, Xpert Ultra sensitivity against culture in Perez-Risco 2018 was 88% (47 to 100).

    “In bone or joint aspirate, Xpert Ultra sensitivity and specificity against culture were 88% (47 to 100) (specificity was not estimable) (Perez‐Risco 2018), and 96% (87 to 100) and 97% (85 to 100) (Sun 2019) (2 studies; 94 participants, 60 (63.8%) with tuberculosis); Appendix 9.”

    From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Perez‐Risco 2018

    The Results section reports sensitivity by broad specimen group, including tissue specimens and abscess aspirates, but gives no bone-or-joint aspirate estimate. Searches of our copy for bone, joint, and the claimed figure found no matching passage, so the 88% sensitivity and its interval cannot be verified. (LLM, conf=0.70)

    Experimental — accuracy not yet measured
  • In peritoneal fluid, Xpert Ultra sensitivity against culture was 33% (1 to 91).

    “In peritoneal fluid, Xpert Ultra sensitivity against culture was 33% (1 to 91) and specificity was not estimable (Perez‐Risco 2018) (1 study; 3 participants); Appendix 10.”

    From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Perez‐Risco 2018

    The Results (page unavailable) report Xpert Ultra sensitivity for broad specimen groups and pleural fluid, but no passage in our copy gives a peritoneal-fluid result. Searches for peritoneal or ascitic fluid, one positive result among three samples, and 33.3% did not establish the claimed 33% sensitivity or 1–91 interval. (LLM, conf=0.70)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [14]14. Zar HJ, Workman L, Nicol MP. 2017. Diagnosis of pulmonary tuberculosis in HIV-infected and uninfected children using Xpert MTB/RIF Ultra, abstr A7610. ATS 2017 International Conference. American Thoracic Society, Washington, DC.

Cited by

Sorted by citations

Authors
Perez-Risco, D., Rodriguez-Temporal, D., Valledor-Sanchez, I., & Alcaide, F.
Affiliations
  • Bellvitge University Hospital (ES)
  • Department of Microbiology, Hospital Universitari de Bellvitge-IDIBELL, Hospitalet de Llobregat, Spain
Venue
Journal of Clinical Microbiology
Published
2018-09
Volume
56
Issue
9
ISSN
  • 0095-1137 (ISSN-L)
  • 1098-660X
OpenAlex
W2808815524
Cited by
103
References
28
Citations by year
2026: 2 · 2025: 8 · 2024: 11 · 2023: 12 · 2022: 9 · 2021: 14 · 2020: 25 · 2019: 21 · 2018: 1
FWCI
11.52
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Microbiology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
  • Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
  • Health Sciences › Medicine › Surgery › Infectious Diseases and Tuberculosis
Keywords
Xpert MTB/RIF Ultra, Mycobacterium tuberculosis complex, extrapulmonary tuberculosis, nucleic acid amplification tests, sensitivity and specificity, nontuberculous mycobacteria, pleural fluid, rapid diagnosis
MeSH terms
Adult, Antibiotics, Antitubercular, Diagnostic Tests, Routine, Humans, Mycobacterium tuberculosis, Nontuberculous Mycobacteria, Rifampin, Sensitivity and Specificity, Time Factors, Tuberculosis, Drug Resistance, Bacterial, Molecular Diagnostic Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review